GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Compound class:
Synthetic organic
Comment: BDM91288 is a pyridylpiperazine-based bacterial efflux pump inhibitor (EPI) with improved drug-like properties compared to earlier inhibitors from the series such as BDM88855 [1]. It has potent activity against the resistance-nodulation-division (RND) family of efflux pumps of Enterobacteriaceae, binding to AcrB, the inner membrane component of the AcrAB-TolC efflux pump [1]. EPIs have potential clinical utility as adjunctive therapeutic agents for the treatment of infections caused by Gram-negative pathogens.
|
|
|||||||||||||||||||||||||||||||||||
| References |
|
1. Vieira Da Cruz A, Jiménez-Castellanos JC, Börnsen C, Van Maele L, Compagne N, Pradel E, Müller RT, Meurillon V, Soulard D, Piveteau C et al.. (2024)
Pyridylpiperazine efflux pump inhibitor boosts in vivo antibiotic efficacy against K. pneumoniae. EMBO Mol Med, 16 (1): 93-111. [PMID:38177534] |